Free Trial

STAAR Surgical (STAA) Competitors

STAAR Surgical logo
$18.26 -0.28 (-1.51%)
Closing price 04/30/2025 04:00 PM Eastern
Extended Trading
$18.02 -0.24 (-1.31%)
As of 07:09 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

STAA vs. ICUI, HAE, XRAY, QDEL, NEOG, CERS, OSUR, ANIK, UTMD, and COO

Should you be buying STAAR Surgical stock or one of its competitors? The main competitors of STAAR Surgical include ICU Medical (ICUI), Haemonetics (HAE), DENTSPLY SIRONA (XRAY), QuidelOrtho (QDEL), Neogen (NEOG), Cerus (CERS), OraSure Technologies (OSUR), Anika Therapeutics (ANIK), Utah Medical Products (UTMD), and Cooper Companies (COO). These companies are all part of the "health care supplies" industry.

STAAR Surgical vs.

ICU Medical (NASDAQ:ICUI) and STAAR Surgical (NASDAQ:STAA) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, community ranking, profitability, earnings, risk, media sentiment, institutional ownership and valuation.

ICU Medical has a beta of 0.86, indicating that its share price is 14% less volatile than the S&P 500. Comparatively, STAAR Surgical has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500.

STAAR Surgical has lower revenue, but higher earnings than ICU Medical. STAAR Surgical is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ICU Medical$2.38B1.41-$29.66M-$4.83-28.28
STAAR Surgical$313.90M2.87-$20.21M-$0.41-44.54

96.1% of ICU Medical shares are held by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are held by institutional investors. 1.5% of ICU Medical shares are held by insiders. Comparatively, 1.0% of STAAR Surgical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, ICU Medical had 12 more articles in the media than STAAR Surgical. MarketBeat recorded 20 mentions for ICU Medical and 8 mentions for STAAR Surgical. STAAR Surgical's average media sentiment score of 0.97 beat ICU Medical's score of 0.41 indicating that STAAR Surgical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
ICU Medical
9 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Neutral
STAAR Surgical
4 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

ICU Medical has a net margin of -4.74% compared to STAAR Surgical's net margin of -6.44%. ICU Medical's return on equity of 5.05% beat STAAR Surgical's return on equity.

Company Net Margins Return on Equity Return on Assets
ICU Medical-4.74% 5.05% 2.42%
STAAR Surgical -6.44%-3.35%-2.67%

ICU Medical received 108 more outperform votes than STAAR Surgical when rated by MarketBeat users. Likewise, 64.14% of users gave ICU Medical an outperform vote while only 54.12% of users gave STAAR Surgical an outperform vote.

CompanyUnderperformOutperform
ICU MedicalOutperform Votes
397
64.14%
Underperform Votes
222
35.86%
STAAR SurgicalOutperform Votes
289
54.12%
Underperform Votes
245
45.88%

ICU Medical presently has a consensus price target of $162.67, indicating a potential upside of 19.09%. STAAR Surgical has a consensus price target of $24.25, indicating a potential upside of 32.80%. Given STAAR Surgical's higher probable upside, analysts plainly believe STAAR Surgical is more favorable than ICU Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ICU Medical
0 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.00
STAAR Surgical
1 Sell rating(s)
9 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

ICU Medical beats STAAR Surgical on 13 of the 19 factors compared between the two stocks.

Get STAAR Surgical News Delivered to You Automatically

Sign up to receive the latest news and ratings for STAA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

STAA vs. The Competition

MetricSTAAR SurgicalOphthalmic goods IndustryMedical SectorNASDAQ Exchange
Market Cap$900.68M$11.11B$5.56B$7.83B
Dividend YieldN/A0.96%5.11%4.22%
P/E Ratio-44.5435.9922.4418.48
Price / Sales2.872.81393.95103.59
Price / Cash23.0214.5338.1834.62
Price / Book2.312.386.774.25
Net Income-$20.21M$224.27M$3.22B$248.23M
7 Day Performance2.13%-1.30%1.45%0.89%
1 Month Performance3.75%-9.96%3.96%3.53%
1 Year Performance-59.14%-19.70%16.07%5.08%

STAAR Surgical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
STAA
STAAR Surgical
4.3847 of 5 stars
$18.26
-1.5%
$24.25
+32.8%
-60.3%$900.68M$313.90M-44.54960Upcoming Earnings
Positive News
ICUI
ICU Medical
3.8714 of 5 stars
$135.90
+0.2%
$162.67
+19.7%
+39.5%$3.34B$2.38B-29.7414,500Upcoming Earnings
Positive News
HAE
Haemonetics
4.6248 of 5 stars
$62.55
+0.1%
$101.22
+61.8%
-31.5%$3.14B$1.37B24.632,820Upcoming Earnings
News Coverage
Positive News
XRAY
DENTSPLY SIRONA
4.9016 of 5 stars
$13.87
+0.9%
$22.58
+62.8%
-53.7%$2.76B$3.79B-6.7015,000Upcoming Earnings
Analyst Forecast
Positive News
QDEL
QuidelOrtho
4.5397 of 5 stars
$28.96
+3.1%
$46.83
+61.7%
-31.5%$1.95B$2.78B-0.967,000Upcoming Earnings
News Coverage
Positive News
NEOG
Neogen
3.8084 of 5 stars
$5.14
-0.4%
$9.00
+75.1%
-59.0%$1.12B$906.00M-2.352,110Positive News
CERS
Cerus
2.0773 of 5 stars
$1.34
-0.7%
$3.50
+161.2%
-21.0%$256.15M$180.27M-12.18290News Coverage
OSUR
OraSure Technologies
4.5574 of 5 stars
$3.04
+1.7%
$5.50
+80.9%
-43.5%$227.39M$185.83M20.27840Upcoming Earnings
ANIK
Anika Therapeutics
4.0625 of 5 stars
$14.51
+0.6%
$21.67
+49.3%
-43.9%$205.69M$119.91M-2.18300
UTMD
Utah Medical Products
2.3322 of 5 stars
$52.21
-0.3%
N/A-21.8%$171.35M$40.90M13.22180Earnings Report
News Coverage
COO
Cooper Companies
3.3156 of 5 stars
$81.85
+1.2%
$110.25
+34.7%
-8.3%$16.37B$3.93B41.9714,000Positive News

Related Companies and Tools


This page (NASDAQ:STAA) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners